Email Alert | RSS    帮助

中国防痨杂志 ›› 2008, Vol. 30 ›› Issue (1): 30-32.

• 论著 • 上一篇    下一篇

浙江省第1轮结核分枝杆菌药敏试验室间质量保证结果分析

柳正卫；何海波；   

  1. 浙江省疾病预防控制中心 杭州 310009；
  • 出版日期:2008-01-10 发布日期:2011-11-03

Analysis of first round EQA results for DST of MTB in Zhejiang province

Liu Zhengwei,He Haibo   

  1. Zhejiang Center for Disease Control and Prevention,Hangzhou 310009,China
  • Online:2008-01-10 Published:2011-11-03

PDF (PC)

730

摘要： 目的　组织全省市级结核病参比实验室开展结核分枝杆菌药敏试验的实验室室间比对,分析评价比对结果,规范和完善药敏试验室间质量保证体系。方法 采用WHO推荐的比例法对质控菌株进行药敏试验。结果 全省12个实验室完成并上报比对结果的为10个。各药物总的一致率分别为:异烟肼92.0%,利福平96.7%,链霉素83.3%,乙胺丁醇90.6%。结论 全省总的药敏试验水平基本达到了WHO/IUATLD对开展药物敏感性试验所需的要求,但部分实验室检测水平有待提高。

关键词: 分枝杆菌,结核, 药敏, 质量保证

Abstract: Objective To organize the municipal TB reference labs in ZheJiang province to be proficiency test for drug susceptibility testing(DST) of MTB,and perfect the external quality assurance(EQA) standard of DST through analyze and evaluate the testing results.Methods We adopted the proportinal method for this proficiency testing of DST that recommended by WHO.Results 10 labs report their Results timely in whole 12 labs,and the general accordance rate about INH,RFP,SM,EMB was 92.0%,96.7%,83.3%,90.7%,respectively.Conclusions The general levels for DST in zhejiang province has reached the WHO’s requirement.But some labs must be strengthen their testing ability for DST.

Key words: Mycobacterum Tuberculosis, DST, EQA

版权所有 © 2021 中国防痨协会　　　京ICP备11029069号-1   京公网安备11010202007215号
ip访问总数:  ip当日访问总数:  当前在线人数:
本作品遵循Creative Commons Attribution 3.0 License授权许可